The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.

by Steven N Steinway, Hien Dang, Hanning You, C Bart Rountree, Wei Ding
Published 2015-01-01

Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cel...

by Nirmala Mavila, David James, Sarah Utley, Nguyen Cu, Orly Coblens, Katrina Mak, C Bart Rountree, Michael Kahn, Kasper S Wang
Published 2012-01-01

A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

by Hephzibah Rani S. Tagaram, Dhimant Desai, Guangfu Li, Dai Liu, C. Bart Rountree, Kavitha Gowda, Arthur Berg, Shantu Amin, Kevin F. Staveley-O’Carroll, Eric T. Kimchi
Published 2016-03-01